AXOLOTL biosciences SRL
AXOLOTL biosciences reported total assets of 119,301 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
By total assets for 2025, AXOLOTL biosciences ranks in the top half of the 1,197 companies in its sector (NACE 8699) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of AXOLOTL biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -11 % Total assets -20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AXOLOTL biosciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 28 Nov 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
AXOLOTL biosciences's financial analysis
- Solvency88.2%sector median: 48.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AXOLOTL biosciences
AXOLOTL biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0844.577.614
- VAT number
- BE0844577614
- Peppol
- Registered · 0208:0844577614 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Mar 2012
- Registered office
- 1060 Saint-Gilles
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Activities in the field of nutrition (NACE 86995)
AXOLOTL biosciences (SRL) has been based in Saint-Gilles since 2012, active in: activities in the field of nutrition. For 2025, it reports a net loss of 1,475 € and equity of 105,273 €; its revenue is not published. Its solvency stands at 88.2%, above the median of its sector (48.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to AXOLOTL biosciences
Companies in the same business, of comparable size and area, outside its group.
- Europees Economisch Samenwerkingsverband voor Homeopathischeen Antroposofische Medische Producten Other human health activities n.e.c. Brussels · balance sheet 152,210 €
- NK Consult Other human health activities n.e.c. Brussels · balance sheet 2,878 €
- Myriam van Vaerenbergh Other human health activities n.e.c. Ixelles · balance sheet 142,935 €
- Actifit Other human health activities n.e.c. Uccle · balance sheet 91,421 €
- Scohy Chiropraktijk - Rugcenter Other human health activities n.e.c. Forest · balance sheet 102,736 €
- Surgex Other human health activities n.e.c. Jalhay · balance sheet 121,981 €
- Cabinet Medical Docteur Wiame Other human health activities n.e.c. Héron · balance sheet 128,345 €
- Idea Gastroenterologie Other human health activities n.e.c. Forest · balance sheet 165,091 €
Frequently asked questions about AXOLOTL biosciences
What is the revenue of AXOLOTL biosciences?
AXOLOTL biosciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AXOLOTL biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0844577614 for AXOLOTL biosciences, if the company is VAT-registered. Its company number (CBE) is 0844.577.614.
Where is the registered office of AXOLOTL biosciences?
According to the CBE register, the registered office of AXOLOTL biosciences is in 1060 Saint-Gilles.
What is the equity of AXOLOTL biosciences?
At the close of the 2025 financial year, the equity of AXOLOTL biosciences amounts to 105,273 €, a solvency of 88.2% of total assets.
Who manages AXOLOTL biosciences?
The register lists 1 active mandates at AXOLOTL biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is AXOLOTL biosciences within its sector?
By total assets for 2025, AXOLOTL biosciences ranks in the top half of the 1,197 companies in its sector (NACE 8699) in Belgium that filed accounts for that financial year.
The full file of AXOLOTL biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →